These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 380326)
41. The role of UV radiation in the prevention of human leukocyte antigen alloimmunization. Andreu G; Boccaccio C; Klaren J; Lecrubier C; Pirenne F; Garcia I; Baudard M; Devers L; Fournel JJ Transfus Med Rev; 1992 Jul; 6(3):212-24. PubMed ID: 1498466 [No Abstract] [Full Text] [Related]
42. Transfusion-associated immune modulation: a reason to TRIM platelet transfusions? Geiger TL Transfusion; 2008 Sep; 48(9):1772-3. PubMed ID: 18811896 [No Abstract] [Full Text] [Related]
43. HLA-reduced platelets to overcome platelet refractoriness: can lemons help? Sirchia G Transfusion; 1996 May; 36(5):388-91. PubMed ID: 8693499 [No Abstract] [Full Text] [Related]
44. Results of HLA antibody testing using ELISA vs the fluorescent bead method and retrospective review of data for recipients of packed RBCs and platelets from male HLA-immunized donors. Aung FM; Cano P; Fernandez-Vina M; Lichtiger B Am J Clin Pathol; 2011 Jan; 135(1):90-5. PubMed ID: 21173129 [TBL] [Abstract][Full Text] [Related]
46. Predictive value of cross-matching for transfusion of platelet concentrates to alloimmunized recipients. Filip DJ; Duquesnoy RJ; Aster RH Am J Hematol; 1976; 1(4):471-9. PubMed ID: 1008059 [TBL] [Abstract][Full Text] [Related]
47. The human histocompatibility complex: a review for the hematologist. Miller WV Prog Hematol; 1977; 10():173-91. PubMed ID: 337359 [No Abstract] [Full Text] [Related]
48. HLA--C antigens on platelets. Mueller-Eckhardt G; Hauck M; Kayser W; Mueller-Eckhardt C Tissue Antigens; 1980 Jul; 16(1):91-4. PubMed ID: 6970427 [TBL] [Abstract][Full Text] [Related]
49. Use of HLA- and HPA--matched platelets in alloimmunized patients. Kekomäki R Vox Sang; 1998; 74 Suppl 2():359-63. PubMed ID: 9704468 [TBL] [Abstract][Full Text] [Related]
50. Severe anaphylactic transfusion reaction associated with HLA-incompatible platelets. Take H; Tamura J; Sawamura M; Murakami H; Naruse T; Tsuchiya J; Miyawaki S; Hirabayashi H Br J Haematol; 1993 Apr; 83(4):673-4. PubMed ID: 8518185 [No Abstract] [Full Text] [Related]
51. HLA-matched platelets from unrelated donors in the supportive therapy of patients undergoing intensive haematologic treatment. Reali G; Avanzi G; Bacigalupo A; Barbanti M; Ghinatti C; Queirolo MA; Van Lint MT; Marmont A Haematologica; 1978 Oct; 63(5):575-85. PubMed ID: 107077 [No Abstract] [Full Text] [Related]
52. [Platelet transfusion refractoriness and effective management of platelet alloimmunization]. Amemiya Y Nihon Rinsho; 1997 Sep; 55(9):2392-8. PubMed ID: 9301306 [TBL] [Abstract][Full Text] [Related]
54. [Caracterization of HLA allo-immunization and clinical impact in transfusion and organ transplantation]. Delbos F; Cesbron A Transfus Clin Biol; 2017 Sep; 24(3):131-137. PubMed ID: 28757117 [TBL] [Abstract][Full Text] [Related]
55. Human histocompatibility antigens (HLA). Kumar R; Mittal KK Indian Pediatr; 1983 Oct; 20(10):763-70. PubMed ID: 6373600 [No Abstract] [Full Text] [Related]
56. Selection of compatible platelet donors: a prospective evaluation of three cross-matching techniques. Wu KK; Hoak JC; Koepke JA; Thompson JS Transfusion; 1977; 17(6):638-43. PubMed ID: 145673 [TBL] [Abstract][Full Text] [Related]